Related Experiment Video
Updated: Mar 16, 2026

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
Regulatory Evolution of Biologics in India: Innovation Gaps and Strategic Imperatives for Global Leadership
Anshuman Panda1, Biswa Mohan Sahoo1, Chandan Kumar Brahma1
1School of Pharmacy and Life Sciences, Centurion University of Technology & Management, Jatni, Khurda-752050, Odisha, India.
Abstract:
Biologics are the medicinal or diagnostic products obtained from living organisms and intended for human consumption. These products include serums, vaccines, antitoxins, antigens, blood, blood components, gene therapy, and tissues. The Central Drugs Standard Control Organisation (CDSCO) is the Indian national regulatory authority. It is responsible for the manufacturing and import of biological products in India. CDSCO is involved in evaluating the safety, efficacy, and quality of all biologicals in India. The Department of Biotechnology (DBT) governs all biological development and pre-clinical studies. The government of India, DBT, and the Ministry of Science and Technology oversee the Review Committee on Genetic Manipulation (RCGM). Research and development activities, as well as the sharing of genetically modified cell banks, must be approved by the RCGM. The Drugs and Cosmetics Act of 1940 and its subsequent regulations, effective from 1945, also govern the production and import of biologicals. For a new drug to be approved, the applicant is required to file an application in Form 44, along with the prescribed fees and all relevant data as per Schedule Y of the Drugs and Cosmetics Rules. The fundamental principle of the regulations is to ensure high standards of healthcare by making available safe, effective, and quality biologicals to everyone. Additionally, it aims to support the pharmaceutical industry in a manner that enhances public health and benefits patients.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Global Regulatory Systems
Drug Control Governance: Regulatory Bodies and Their Impact

